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Abstract
Background: Complexity and amount of post-genomic data constitute two major factors limiting
the application of Knowledge Discovery in Databases (KDD) methods in life sciences. Bio-
ontologies may nowadays play key roles in knowledge discovery in life science providing semantics
to data and to extracted units, by taking advantage of the progress of Semantic Web technologies
concerning the understanding and availability of tools for knowledge representation, extraction,
and reasoning.
Results: This paper presents a method that exploits bio-ontologies for guiding data selection
within the preparation step of the KDD process. We propose three scenarios in which domain
knowledge and ontology elements such as subsumption, properties, class descriptions, are taken
into account for data selection, before the data mining step. Each of these scenarios is illustrated
within a case-study relative to the search of genotype-phenotype relationships in a familial
hypercholesterolemia dataset. The guiding of data selection based on domain knowledge is analysed
and shows a direct influence on the volume and significance of the data mining results.
Conclusions: The method proposed in this paper is an efficient alternative to numerical methods
for data selection based on domain knowledge. In turn, the results of this study may be reused in
ontology modelling and data integration.
Background
The Knowledge Discovery in Databases (KDD) process is
based on three main operations: data preparation, data
mining, and interpretation of the extracted units. This
process is guided and controlled by an expert of the con-
cerned domain. The KDD process has been successfully
applied in various domains such as marketing, finance,
and biomedicine [1].
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However applications of KDD are limited by the fact that
strong interactions between the system and domain
experts are necessary. Data manipulated in life sciences
are complex and data mining algorithms generate large
volume of rough results. As a consequence, the interpreta-
tion step of KDD in biology, aimed at extracting new and
relevant knowledge units, is a hard task, i.e. time-consum-
ing and tedious for the domain expert.
In computer science, ontologies provide a shared under-
standing of knowledge about a particular domain [2]. Bio-
ontologies are becoming more and more available and
contribute to the understanding of the large amounts of
data existing in life sciences [3]. The National Center for
Biomedical Ontology (NCBO) has recently developed
Bioportal that offers a unified panorama on available bio-
ontologies [4,5].
One of the promising interests of bio-ontologies is their
use for guiding the process of KDD as suggested by Anand
[6], Cespivova [7], Gottgtroy [8], and Napoli [9]. This idea
seems to be much more realistic now that Semantic Web
advances have given rise to common standards and tech-
nologies for expressing and sharing ontologies [10].
In this way, the three main operations of KDD can take
advantage of domain knowledge embedded in bio-ontol-
ogies.
(1) During the data preparation step, bio-ontologies can
facilitate the integration of heterogeneous data and guide
the selection of relevant data to be mined.
(2) During the mining step, domain knowledge allows
the specification of constraints for guiding data mining
algorithms by, e.g. narrowing the search space.
(3) During the interpretation step, domain knowledge
helps experts to visualize and validate extracted units.
There exists a number of studies on the use of ontologies
within the data mining step, e.g. [11,12], and the interpre-
tation step e.g. [13-15]. Only a few studies (detailed here-
after) has focused on the first step, namely data
preparation. This is the purpose of the present paper.
Data preparation –or preprocessing– is aimed at improv-
ing the quality of the data, and consequently the efficiency
of the KDD process. Methods for data preparation involve
operations of different types: data integration, data clean-
ing, data transformation and data reduction [16]. These
operations are not exclusive since they may be combined.
For example, data transformation can have an impact on
data cleaning during normalisation of data. Data integra-
tion can have an impact on data cleaning as well, when
inconsistencies are detected and corrected, or when miss-
ing values are filled. Still regarding data integration, the
use of ontologies has been theoretically and practically
studied in life sciences [17,18]. In this way, we have
defined and used an ontology for integrating data on
genetic variants [19]. Perez-Rey et al. have developed
OntoDataClean, an ontology-based tool aimed at solving
inconsistencies, missing and wrong values in datasets
[20]. Data transformation operation produce formatted
data, i.e. normalised and smoothed data, ready for being
processed by data mining algorithms. Euler and Sholz
propose a special ontology related to the transformation
process [21]. This ontology provides facilities to manipu-
late data by using conceptualization of the transformation
process.
The role of data reduction process is to reduce the descrip-
tion of data, e.g. lowering the number of dimensions
within the data, without altering the integrity of the initial
data set. Strategies for data reduction include the follow-
ings.
– Data cube aggregation produces data cubes for storing
multidimensional aggregated data (e.g. extracted from a
data warehouse) for OLAP analysis [22]. For example,
data on daily sales hold on millions of items and can be
aggregated into monthly sales of some selected categories
of items.
– Dimension reduction leads to the encoding of data in
a reduced format, with or without loss with respect to the
initial data set. For example, principal component analy-
sis can be used for dimensionality reduction that applies
projections of initial data onto a space of a smaller dimen-
sion.
– Data discretization techniques are used to reduce the
number of values of an attribute and consequently facili-
tate interpretation of mining results. Automatic discretiza-
tion methods exist for continuous numerical attributes
that recursively partition the attribute values according to
a given scale. For example, the range of an attribute price
can be divided by the means of histogram analysis into
several intervals, which can in turn be iteratively aggre-
gated into larger intervals. However, these methods do
not apply for discrete or nominal attributes, when the
attribute values of which are not ordered. The scale for an
attribute has then to be manually defined by domain
experts and possibly refined with the help of heuristic
methods [23].
– Data selection aims at identifying appropriate subsets
among the initial set of attributes. This operation can be
performed with the help of heuristic methods based on
tests of significance or entropy-based attribute evaluationBMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
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measures such as the information gain [24,25]. Data
selection is one of the data reduction methods that is stud-
ied in this paper.
The use of domain knowledge in KDD process can be con-
sidered from two points of view. The first one uses knowl-
edge about the KDD process itself, i.e. domain
represented within ontologies are data transformation,
data cleaning, or the whole KDD domain [26]. The second
one uses knowledge related to the dataset domain [18],
e.g. pharmacogenomics. The work presented in this article
follows the second view, and focuses on data preparation,
and more precisely, on data selection. In addition it is
made precise how available domain knowledge –con-
tained in a knowledge base (KB)– can assist the domain
expert in selecting relevant attributes or object subsets.
Our case-study deals with genotype-phenotype relation-
ships. Finding relationships between genotype and phe-
notype is of primary interest in biological research. Large
scale clinical studies provide large mass of genomic and
post-genomic data produced by high-throughput biotech-
nology devices (e.g. microarray, mass spectrometry).
Recent studies [27-29] have shown that data mining
methods can be used for extracting unexpected and hid-
den correlations between genotype and phenotype. How-
ever, these studies also illustrate the difficulty of achieving
these analyses, mainly because of domain complexity and
large volume of data to be analysed. Keeping this in mind,
we will illustrate here the benefits of using ontology for
data selection within a KDD process, whose objective is to
extract relationships between genomic variants and phe-
notype traits. The data sources explored in the experience
described in this paper have two origins: (i) there are pri-
vate datasets resulting from clinical investigations relative
to Familial Hypercholesterolemia (FH), (ii) there are pub-
lic databases (i.e. dbSNP, HapMap, OMIM, and Locus
Specific Databases) partially integrated within SNP-KB, a
knowledge-base developed in our laboratory. An example
of expected relationships that can be of interest, is in con-
cern with modulator variants, i.e. any genomic variant (or
group of variants) related to disease or disease symptom
modulation. Various levels of severity are for example
observed in FH depending on allele versions of two
genomic variants in the APOE gene (rs7412 and
rs429358) [30]. Modulator variants are of particular inter-
est in pharmacogenomics since they are known to modu-
late the metabolism and effect of drugs [31].
The next section on results presents an overview of the
ontology-guided data selection method. Three scenarios
of data selection are described and illustrate the proposi-
tion and its advantages.
Results
Overview
An overview of the method is given in Figure 1. Data rele-
vant to the study are collected from various resources such
as genomic variation databases, published pharmacoge-
nomic studies and private datasets. Various operations are
applied to these data: cleaning, integration and transfor-
mation. These operations aimed first at participating in
the instantiation of an existing KB, and second at produc-
ing the “initial dataset”. In this study, a dataset is defined
as a relation between set of objects (rows) and set of
attributes (columns). A mapping is then built between
objects and attributes of this dataset, and instances of the
KB. Data selection results from the definition of a subset
of instances in the KB, allowing the selection of corre-
sponding objects and attributes with respect to the map-
ping. This process that takes as inputs the initial dataset
and the KB, is controlled by the domain expert, and yields
the “reduced dataset”. Characteristics of the ontology such
as subsumption relationships, properties and class
descriptions, are used to guide the choice of meaningful
instance subsets. These subsets are in turn used for data
selection. Data mining algorithms are then applied to the
reduced dataset. In the three examples presented hereaf-
ter, two mining algorithms are used. The first algorithm is
Zart that extracts Frequent Itemsets (FI) and Frequent
Closed Itemsets (FCI). The latter are special itemsets that
cannot be extended in the dataset (see the Methods sec-
tion). The ratio FI / FCI increases with the redundancy
level of the itemsets. The second algorithm is COBWEB,
which carries on a clustering of data in an unsupervised
way. Actually, the results of the clustering are simply char-
acterized by the number of obtained clusters.
Articulation between data and knowledge
Our method is based on a mapping between objects and
attributes of the dataset, and instances of the KB. Thus,
formalized knowledge within the KB can be used for guid-
ing data selection. Figure 2 illustrates this mapping in the
case of genomic variants assigned to concepts of the SNP-
KB such as conserved domain_variant,  coding_variant,
non_coding_variant, haplotype_member or tag_snp.
The efficiency of the interaction between data and knowl-
edge is mainly based on the instantiation process in the
KB with collected data. This process is dependent on data
integration issues and has to be controlled by the domain
expert, who has to choose the most accurate class corre-
sponding to the considered data. In this way, the domain
expert is in charge of instantiating the right classes in the
knowledge base. In practice, information about the map-
ping is stored in the KB during the instantiation process by
adding a property to the created instance. It can be noticed
that depending on modelling choices, one object or oneBMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
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attribute can be mapped to more than one instance. Three
concrete scenarios for data selection are now described.
Progressive selection of specific variants – guided by 
subsumption
The first scenario assumes that significant relationships
between genotypes and phenotypes can be easily
extracted from a reduced dataset, in which only coding
variants or variants of conserved protein domains are con-
sidered. In our method, this kind of reduction results
from the selection in the SNP-KB of a subset of instances
corresponding to most specific and adequate classes in the
ontology, with respect to subsumption relationships. As
illustrated in Table 1, a progressive selection of the most
specific variant instances, successively belonging to variant
class and coding_variant and conserved_domain_variant sub-
classes, leads to a decreasing number of attributes related
to variants in the dataset: progressively 289, 231, and 126
attributes. In practice, the guiding of instance selection is
managed through a plug-in of Protégé 4 adapted for this
purpose (see the Methods section).
Table 1 shows in addition the amount of data mining
results obtained when most specific classes of variants are
selected. When all variants are considered (variant col-
umn), the total number of FI computed by Zart is 6928.
With COBWEB, the total number of clusters is 194. At
present, these results are complex to interpret due to the
large volume of involved variants and the lack of contex-
tual data. For example, coding and non coding variants
cannot be distinguished.
The volume of data mining results progressively decreases
as more reduced sets of variants are selected
(coding_variant and conserved_domain_variant columns).
This reduction can be read on the number of FI –from
Overview of the proposed method Figure 1
Overview of the proposed method The KDD process is divided into three main steps: data preparation, data mining, and 
data interpretation. The figure details data preparation within the KDD process and illustrates our method of data selection 
guided with domain knowledge. Data relevant to the study are collected from various resources such as genomic variation 
databases, published pharmacogenomic studies and private datasets. Various operations are applied to these data: cleaning, 
integration and transformation. Theses operations implies first an instantiation of a knowledge base (1), and second the design 
of the “initial dataset”(2). In this study, a dataset is defined as a relation between set of objects (rows) and set of attributes (col-
umns). A mapping is then built between objects and attributes of this dataset and the instances from the KB (3). Data selection 
results from the definition of a subset of instances in the KB (4), allowing the selection of corresponding objects and attributes, 
with respect to the mapping. This process takes as inputs the initial dataset and the KB is controlled by the domain expert, and 
yields the “reduced dataset”. Characteristics of the ontology such as subsumption relationships, properties and class descrip-
tions, are used to guide the definition of meaningful instance subsets. These subsets are in turn used for data selection. Data 
mining algorithms are then applied to the reduced dataset. The results of the mining operation are interpreted in terms of 
knowledge units that can be eventually integrated into the knowledge base.BMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
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6928 to 304– and of clusters –from 194 to 56– making
results easier to interpret.
Being able to use subsumption relationships between
ontology classes for guiding data selection is one main
advantage resulting from the knowledge formalization
effort, data integration and data cleaning preceding the
SNP-KB instantiation.
Tag-SNP based variant unification – guided by object 
properties
The examination of the data mining results obtained with
the complete variant dataset reveals a high proportion of
trivial and redundant association rules. This reflects the
existence of variants belonging to the same haplotype. In
simple words, ahaplotype designates a group of variants
that segregate uniformly and can be replaced by a smaller
group of variant, called “tag-SNPs”. Replacing all mem-
bers of a haplotype by corresponding tag-SNP(s) may
lower the number of extracted redundant association
rules.
Figure 3 shows a haplotype composed of variants rs_004,
rs_005, rs_006 and rs_007, that can be replaced by the
unique rs_007 tag-SNP. This information, which actually
depends on the description of a given haplotype
(NA01234), enlightens a functional dependency between
variant rs_004 (or rs_005 or rs_006) and rs_007. Such a
functional dependency can be expressed in the SNP-
knowledge base as follows.
rs_004 := isHaplotypeMemberOf(haplotype_NA01234)
rs_004 := isHaplotypeMemberOf(isTaggedBy (rs_007))
A knowledge base may include information about func-
tional dependencies taking the form of object properties
(or sequences of object properties). Since the SNP-KB
includes haplotype descriptions issued from the HapMap
project [32] and Haploview software [33], and includes
isHaplotypeMemberOf and isTaggedBy properties, then it is
possible to distinguish between tag-SNPs and other hap-
lotype members in the SNP-KB. According to our method,
Articulation between data and knowledge Figure 2
Articulation between data and knowledge Some classes of SNP- and SO-Pharm ontologies are shown as well as their 
assigned instances. The mapping between objects and attributes of the FH dataset, and instances of the KB is schematized.
Table 1: Quantitative characterization of data mining results depending on attribute selection. Table 1 gives quantitative information 
about output (number of itemsets and number of clusters) for two data mining methods involved in this experiment. A column 
corresponds to a various selection of attribute in the FH dataset.
variant coding_variant conserved_domain_variant tag_snp
Number of Variants 289 231 126 198
FI (FCI) {ratio FI/FCI} 6928 (255) {27. 17} 314 (24) {13.08} 304 (12) {25.33} 300(28){10.71}
Clusters 194 186 56 40BMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
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reducing the dataset to tag-SNPs is based on the selection
of a subset of variant instances of the tag_snp class. In the
situation depicted in Figure 3, this implies in turn the
removal of columns rs_004, rs_005, and rs_006 in the
dataset.
Applied to the FH initial dataset, this strategy considerably
reduces the number of attributes (see Table 1, compare
the variant and tag_snp columns). The volume of extracted
units to be interpreted is thus also considerably reduced,
not only because of the lower number of attributes but
also because of the reduced number of dependencies
between selected attributes (see the percentage of non
redundant rules). One main advantage of guiding this
selection process with domain ontology is to dynamically
use the representation of functional dependencies
between simple haplotype members and representative
tag-SNPs in the SNP-KB. The representation is dependent
on the precision of haplotype construction and may
evolve. Automated updating of haplotype representation
and instantiation in the SNP-KB is under study.
Patient selection – guided by class definition and 
classification
In contrast with the two previous scenarios dedicated to
attribute selection, e.g. variant, this paragraph illustrates
object selection, e.g. patient selection, leading to a reduc-
tion of the dataset as well. This third scenario illustrates
the selection of instances based on the description of
classes within SO-Pharm ontology. SO-Pharm encom-
passes and extends SNP-Ontology (see Methods section).
In the FH case study, groups of patients suspected to
present specific genotype-phenotype profiles are defined.
Classes and properties of SO-Pharm allow to define four
classes of patients: one already existing in SO-Pharm, and
three others that are defined for the data selection.
patient (defined in SO-Pharm)
patient_α ≡ patient  ∃ presentsGenotypeItem ( 
(LDLR_mutation))
patient_β ≡ patient  ∃ presentsGenotypeItem ( 
(no_LDLR_mutation))
 ∃ presentsPhenotypeItem ( (high_LDL_in_blood))




Reasoning mechanisms as applied to instances classify
patients according to their individual properties. This
allows to detect and to select a set of objects sharing the
same attributes, as a set of instances belonging to the same
class. This selection may reduce the volume of data input
for subsequent mining tasks, and allows the characteriza-
tion and comparison of selected subgroups.
Discussion
Data selection is a crucial step in KDD process and any
attention paid to selection makes more efficient the KDD
process. Indeed, the computational cost in space and time
of data mining algorithms is exponential (at worst), and
any reduction of the initial dataset has effect on the whole
data mining process. In addition, the practical use of data
mining algorithms is also often limited by size of datasets
or machine capabilities. For example, the extraction of fre-
quent itemsets from the FH dataset on a standard worksta-
tion with a Pentium 1.8Ghz and 2Mb of RAM has to be
limited to the calculation of the “most frequent” itemsets
since the minimum support has to be set very high (i.e.
96%). Data selection is an important operation participat-
ing to the preparation step of the KDD, allowing the data
mining algorithm to handle large dataset. Comparative
tests show that data selection reduces quite always the vol-
ume of results and, in some cases, the redundancy within
the extracted units. The efficiency of data selection is not
so surprising and demonstrates, to a certain extent, some
advantages of using ontology. More importantly, an
actual positive feedback from the domain expert has been
observed, who has enthusiastically piloted the data selec-
tion, being assisted by an ontology. The smaller size of the
results has been a second cause of satisfaction for the
domain expert, since results of the data mining tests have
revealed non-standard results that may be of interest with
respect to the domain knowledge.
Ontology-guided data selection can be performed by tak-
ing advantage of subsumption relationships between
ontology classes and by defining subsets of instances cor-
Tag-SNP variant unification Figure 3
Tag-SNP variant unification. This figure focuses on some 
classes and instances from Figure 2. It develops the descrip-
tion of Haplotype and the isHaplotypeMemberOf and 
isTaggedBy object properties used for illustrating functional 
dependencies between instances of variants and tag_snp.BMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
Page 7 of 9
(page number not for citation purposes)
responding to the most specific classes. When association
rules have been extracted from a reduced dataset, the sub-
sumption relationships can be followed within the ontol-
ogy, for generalizing the association rules. This bottom-up
traversal of the ontology can be used, for example, to
check whether an extracted association rule between a
coding variant and a phenotypic trait can be extended to
some non-coding variants. This kind of association may
be observed when intron splice sites are affected as dis-
cussed in [34].
Conclusions
This paper illustrates how domain knowledge captured in
bio-ontologies facilitates the KDD process. An approach
for data selection has been proposed that takes good
advantage of time and effort spent for the KB construc-
tion.
Three proposed scenarios of data selection can be com-
bined in order to define optimized KDD strategies fulfill-
ing biomedical objectives. For that purpose, additional
scenarios can be planned such as object unification, i.e.
grouping together patients from the same family and
retaining a unique representative for the family, thus
reducing the number of objects to be manipulated. The
selection process depends on instance properties (object
and data properties), and accordingly on data and instan-
tiation quality. When an instance is missing or presents a
fault, the selection will be erroneous or impossible. In this
way, the available knowledge on haplotypes could also be
used for completing missing values about observed alleles
of each member of a haplotype.
Challenging future work consists in automatically formal-
izing the results of the KDD process within a knowledge
representation language, for enriching both the ontology
and the KB. Such a capability allows to iteratively run the
KDD process, using more complete domain knowledge
after each KDD iteration.
Methods
The FH dataset
Objects in the FH datasets are patients of a clinical study
related to Familial Hypercholesterolemia. Attributes are
data relative to the phenotype or the genotype of the
patients.
The dataset concerns:
(α) patients affected by the genetic hypercholesterolemia
(FH),
(β) patients affected by a non-genetic hypercholestero-
lemia, and
(γ) patients without any hypercholesterolemia.
Majority of genotype attributes (289/293) describes
observed alleles for genomic variants of the LDLR gene.
An example of genotype attribute is the observed allele for
the variant located at position Chr19:11085058 (e.g. AA).
Phenotype attributes describe traits usually observed
when studying the metabolism of lipids. Two examples of
phenotype attributes are the LDL blood concentration
(e.g. [LDL]b=3gl−1) and the presence/absence of xan-
thoma. Table 2 describes quantitatively the dataset.
SNP-Ontology and SO-Pharm
The SNP-Ontology [35] includes a formal representation
in OWL-DL (i.e. the Ontology Web Language) of genomic
variations and their related concepts: sequence in which
they are observed, haplotype they belong to, proteins they
modify, database in which they are stored, etc. For this
study, a SNP-Knowledge Base (SNP-KB) is populated
according to the semantic structure of the SNP-Ontology
and integrating knowledge about genomic variations of
the LDLR gene (Figure 2). Partially integrated data sources
are dbSNP, HapMap, OMIM and private or public Locus
Specific Databases [36]. The method used to populate the
SNP-KB is described precisely in [19].
SO-Pharm is an OWL-DL ontology embedding knowl-
edge about clinical studies in pharmacogenomics [37,38].
SO-Pharm satisfies all quality principles defined by the
OBO Foundry [39]. It is closely articulated with the SNP-
Ontology as with other ontologies that include knowl-
edge about other pharmacogenomics sub-domains, i.e.
related to drug, genotype, and phenotype. SO-Pharm and
articulated ontologies are used to guide the data selection
process.
Knowledge management and instance selection tools
Instantiation of classes in the ontologies is managed both
with Protégé [40] and Jena API [41]. Consistency checking
and classification are carried on with Pellet 1.4 [42]. Prac-
tically, the instance selection is performed through an
adapted Protégé 4 plug-in [43]. This plug-in allows the
Table 2: Characteristics of the FH dataset. The FH dataset 
results from a clinical study relative to Familial 
Hypercholesterolemia. Its size and composition are described in 
Table 2. Phenotype refers to phenotypic attributes including for 
instance LDL concentration in blood. Genotype attributes 
include 289 genomic variations of the LDLR gene and 3 attributes 




Genotype 292BMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
Page 8 of 9
(page number not for citation purposes)
selection of instances sharing characteristics, e.g. class
membership, properties, relation with another specific
instance, (a) by browsing and selecting items in hierar-
chies of classes, object properties and list of instances in a
KB, (b) by answering DL queries with complex restric-
tions. This plug-in is currently under development and is
planned to be released in a near future for the scientific
community.
Data mining methods
Data mining tests have been run on the FH dataset with
two different unsupervised algorithms. The first one,
named Zart, extracts association rules after searching for
frequent itemsets [44,45]. Zart generates itemsets of the
form “ABC” from which in turn is derived an association
rules such as “AB implies C”. An itemset is characterized by
its support, i.e. the frequency of its occurrence in the data-
set. Frequent Itemsets (FI) are itemsets with a support
greater to a minimum threshold or minimum support,
which has to be fixed by the domain expert. Frequent
Closed Itemsets (FCI) are FI having the characteristic of
not being included in any superset, i.e. a larger itemset,
with the same support. Zart has been parameterized with
a minimum support of 96% for the experiment. The prin-
cipal motivation for using Zart is that this algorithm gen-
erates FI, FCI, and in addition, the so-called minimal
generators allowing to infer the set of minimal non-
redundant association rules. COBWEB is a second algo-
rithm designing a structural clustering [46]. COBWEB is
parameterized with an acuity=1 and a cutoff=0.5 that
affect the construction of clusters with constraints on their
relation and their cardinality. COBWEB is an algorithm of
interest in the present study, because it generates a cluster
hierarchy that can be reused in parallel with FI and FCI
(the use of these clusters is planned in a future work).
The implementations of Zart and COBWEB mentioned
just before are available respectively in the Coron plat-
form [47] and the Weka toolbox [48].
List of abbreviations used
API – Application Programming Interface
dbSNP – Single Nucleotide Polymorphism database
DL – Description Logics
FCI – Frequent Closed Itemset
FH – Familial Hypercholesterolemia
FI – Frequent Itemset
KB – Knowledge Base
KDD – Knowledge Discovery in Database
LDL – Low-Density Lipoprotein
LDLR – Low-Density Lipoprotein Receptor
NCBO – National Center for Biomedical Ontology
OBO – Open Biomedical Ontologies
OLAP – Online Analytical Processing
OMIM – Online Mendelian Inheritance in Man
OWL – Web Ontology Language
RAM – Random Access Memory
SNP – Single Nucleotide Polymorphism
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AN carried the initial purpose of using domain knowledge
in KDD process. AC, MS, MDD designed the method. AC
implemented the framework and performed tests. PB car-
ried out the FH clinical study and analyse data selection
and data mining results. AC, MS, AN, MDD contributed to
write the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
This work has been partly funded by a European EUREKA-labelled research 
and development project, and the PRST “Intelligence Logicielle” (a Région 
Lorraine research project). The authors would like to thank the members 
of ISIBio working group and the participants of the Semantic Web summer 
school SWWW'06 for stimulating interactions.
This article has been published as part of BMC Bioinformatics Volume 9 Sup-
plement 4, 2008: A Semantic Web for Bioinformatics: Goals, Tools, Sys-
tems, Applications. The full contents of the supplement are available online 
at http://www.biomedcentral.com/1471-2105/9?issue=S4.
References
1. Frawley W, Piatetsky-Shapiro G, Matheus C: Knowledge Discov-
ery in Databases: An Overview.  In Knowledge Discovery in Data-
bases Edited by: Piatetsky-Shapiro G, Frawley WJ. Cambridge: AAAI/MIT
Press; 1991:1-30. 
2. Gruber TR: A Translation Approach to Portable Ontology
Specifications.  Knowledge Acquisition 1993, 5:199-220.
3. Bodenreider O, Stevens R: Bio-ontologies: current trends and
future directions.  Briefings in Bioinformatics 2006, 7(3):256-274.
4. Bioportal.  . [http://www.bioontology.org/tools/portal/biopor
tal.html]
5. Rubin DL, Lewis SE, Mungall CJ, Misra S, Westerfield M, Ashburner
M, Sim I, Chute CG, Solbrig H, Storey MA, Smith B, Day-Richter J,
Noy NF, Musen MA: National Center for Biomedical Ontology:
Advancing Biomedicine through Structured Organization of
Scientific Knowledge.  OMICS 2006, 10(2):185-198.BMC Bioinformatics 2008, 9(Suppl 4):S3 http://www.biomedcentral.com/1471-2105/9/S4/S3
Page 9 of 9
(page number not for citation purposes)
6. Anand S, Bell D, Hughes J: The Role of Domain Knowledge in
Data Mining.  In Proceedings of the Conference on Information and
Knowledge Management: 29 November – 02 December 1995; Baltimore
New-York: ACM; 1995:37-43. 
7. Cespivova H, Rauch J, Svatek V, Kejkula M, Tomeckova M: Roles of
Medical Ontology in Association Mining CRISP-DM Cycle.
Proceedings of the ECML/PKDD04 Workshop on Knowledge Discovery and
Ontologies: 24 September 2004; Pisa 2004.
8. Gottgtroy P, Kasabov N, MacDonell S: An ontology driven
approach for knowledge discovery in biomedicine.  In Proceed-
ings of the 8th Pacific Rim International Conference on Artificial Intelligence:
9-13 August 2004; Auckland Berlin: Springer; 2004. 
9. Napoli A: Elements on KDDK: Knowledge Discovery guided
by Domain Knowledge.  Proceedings of the Conference on Concept
Lattices and their Applications: 30 October – 1 November; Hammamet
2006.
10. OWL Web Ontology Language Overview.  .  [ h t t p : / /
www.w3.org/TR/owl-features/]
11. Karel F, Kléma J: Quantitative association rule mining in
genomics using apriori knowledge.  Proceedings of the ECML/
PKDD07 Workshop Prior Conceptual Knowledge in Machine LEarning and
Data Mining: 21 September; Warsaw 2007:53-64.
12. Nazeri Z, Bloedorn E: Exploiting Available Domain Knowledge
to Improve Mining Aviation Safety and Network Security
Data.  Proceedings of the ECML/PKDD04 Workshop on Knowledge Dis-
covery and Ontologies: 24 September 2004; Pisa 2004.
13. Liu B, Hsu W, Chen S, Ma Y: Analyzing the subjective interest-
ingness of association rules.  IEEE Intellgent Systems 2000,
15:47-55.
14. Srikant R, Agrawal R: Mining generalized association rules.  Pro-
ceedings of the 21th Very Large Data Bases Conference 8-10 September
1995; Zurich 1995:407-419.
15. Svatek V, Rauch J, Flek M: Ontology-Based Explanation of Dis-
covered Associations in the Domain of Social Reality.  Pro-
ceeding of the ECML/PKDD05 Workshop on Knowledge Discovery and
Ontologies: 7 October 2005; Porto 2005.
16. Han J, Kamber M: Data Mining: Concepts and Techniques San-Francisco:
Morgan Kaufmann Publishers; 2000. 
17. Goble CA, Stevens R, Ng G, Bechhofer S, Paton NW, Baker PG, Peim
M, Brass A: Transparent Access to Multiple Bioinformatics
Information Sources.  IBM Systems Journal Special issue on deep com-
puting for the life sciences 2001, 40:532-551.
18. Köhler J, Philippi S, Lange M: SEMEDA: ontology based semantic
integration of biological databases.  Bioinformatics 2003,
19(18):2420-7.
19. Coulet A, Smaïl-Tabbone M, Benlian P, Napoli A, Devignes MD: SNP-
Converter: An Ontology-Based Solution to Reconcile Heter-
ogeneous SNP Descriptions.  In Proceedings of the Workshop on
Data Integration in the Life Sciences 20-22 July 2006; Hinxton Berlin:
Springer; 2006:82-93.  LNBI 4075
20. Pérez-Rey D, Anguita A, Crespo J: OntoDataClean: Ontology-
Based Integration and Preprocessing of Distributed Data.  In
Proceedings of the International Symposium on Medical Data Analysis 7-8
December; Thessaloniki Berlin: Springer; 2006:262-272.  LNBI 4345
21. Euler T, Scholz M: Using Ontologies in a KDD Workbench.  Pro-
ceedings of the ECML/PKDD04 Workshop on Knowledge Discovery and
Ontologies 24 September 2004; Pisa 2004.
22. Agarwal S, Agrawal R, Deshpande P, Gupta A, Naughton J, Ram-
akrishnan R, Sarawagi S: On the Computation of Multidimen-
sional Aggregates.  I n  Proceedings of the Very Large Data Bases
Conference 03 – 06 September 1996; Bombay San-Francisco: Morgan
Kaufmann Publishers Inc.; 1996:506-521. 
23. Han J, Fu Y: Dynamic Generation and Refinement of Concept
Hierarchies for Knowledge Discovery in Databases.  In Pro-
ceedings of the AAAI Workshop on Knowledge Discovery in Databases 31
July – 4 August 1994; Seattle AAAI Press; 1994:157-168. 
24. Han J: Feature selection based on rough set and information
entropy.  Proceedings of the IEEE International Conference on Granular
Computing: 25-27 July 2005; Beijing 2005, 1:153-158.
25. Kohavi R, John GH: Wrappers for feature subset selection.  Arti-
ficial Intelligence 1997, 97:273-324.
26. Bernstein A, Provost F, Hill S: Toward intelligent assistance for
a data mining process an ontology-based approach for cost-
sensitive classification.  IEEE Transactions on Knowledge and Data
Engineering 2005, 17:503-518.
27. Creighton C, Hanash S: Mining gene expression databases for
association rules.  Bioinformatics 2003, 19:79-86.
28. Capriotti E, Fariselli P, Calabrese R, Casadio R: Predicting Protein
Stability Changes from Sequences Using Support Vector
Machines.  Bioinformatics 2005, 21:ii54-ii58.
29. Li J, Zhou Y, Elston RC: Haplotype-based Quantitative Trait
Mapping Using a Clustering Algorithm.  BMC Bioinformatics
2006, 7:258.
30. Ng MCY, Baum L, So WY, Lam VKL, Wang Y, Poon E, Tomlinson B,
Cheng S, Lindpaintner K, Chan JCN: Association of lipoprotein
lipase S447X, apolipoprotein E exon 4, and apoC3 -455T-C
polymorphisms on the susceptibility to diabetic nephropa-
thy.  Clin Genet 2006, 70:20-28.
31. Giacomini KM, Brett CM, Altman RB, et al.: The pharmacogenet-
ics research network from SNP discovery to clinical drug
response.  Clin Pharmacol Ther 2007, 81(3):328-45.
32. HapMap.  . [http://www.hapmap.org/]
33. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visu-
alization of LD and haplotype maps.  Bioinformatics 2005,
21(2):263-5.
34. Hastings ML, Resta N, Traum D, Stella A, Guanti G, Krainer AR: An
LKB1 AT-AC intron mutation causes Peutz-Jeghers syn-
drome via splicing at noncanonical cryptic splice sites.  Nat
Struct Mol Biol 2005, 12(1):54-59.
35. SNP-Ontology.  . [http://www.bioontology.org/files/6723/
snpontology_full.owl]
36. WayStation.  . [http://www.centralmutations.org/]
37. SO-Pharm.  . [http://www.obofoundry.org/cgi-bin/
detail.cgi?id=pharmacogenomics]
38. Coulet A, Smaïl-Tabbone M, Napoli A, Devignes MD: Suggested
Ontology for Pharmacogenomics (SO-Pharm): Modular
Construction and Preliminary Testing.  In Proceedings of the
Wokshop on Knowledge Systems in Bioinformatics 29 October 2006;
Montpellier Berlin: Springer; 2006:648-57.  LNCS 4277
39. Open Biomedical Ontologies (OBO) Foundry.  . [http://obo
foundry.org]
40. Knublauch H, Fergerson RW, Noy NF, Musen MA: The Protégé
OWL Plugin: An Open Development Environment for
Semantic Web Applications.  In Proceedings of the Third Interna-
tional Semantic Web Conference 7-11 November 2004; Hiroshima Berlin:
Springer; 2004. 
41. McBride B: Jena: Implementing the RDF Model and Syntax
Specification.  Proceedings of the WWW2001 Workshop on the
Semantic Web 1 May 2001; Hong Kong 2001.
42. Sirin E, Parsia B: Pellet: An OWL DL Reasoner.  Proceedings of the
Workshop on Description Logics 6-8 June 2004; Whistler 2004.
43. Protégé 4 alpha plugins.  . [http://www.co-ode.org/downloads/
protege-x/plugins.php]
44. Agrawal R, Imielinski T, Swami AN: Mining Association Rules
between Sets of Items in Large Databases.  SIGMOD 1993,
22(2):207.
45. Szathmary L, Napoli A, Kuznetsov SO: ZART: A Multifunctional
Itemset Mining Algorithm.  Proceedings of the 5th International Con-
ference on Concept Lattices and Their Applications 24-26 October 2007;
Montpellier 2007.
46. Fisher DH: Knowledge Acquisition via Incremental Concep-
tual Clustering.  Machine Learning 1987, 2:139-172.
47. Szathmary L, Napoli A: CORON: A Framework for Levelwise
Itemset Mining Algorithms.  Supplementary Proceedings of the Third
International Conference on Formal Concept Analysis 14-18 February; Lens
2005:110-113.
48. Witten IH, Frank E: Data Mining Practical machine learning tools and
techniques San-Francisco: Morgan Kaufmann Publishers; 2005. 